Uni­ver­si­ty was tipped off to pos­si­ble unau­tho­rized tri­als of her­pes vac­cine

WASH­ING­TON — The uni­ver­si­ty that em­ployed a con­tro­ver­sial her­pes vac­cine re­searcher has told the fed­er­al gov­ern­ment it learned last sum­mer of the pos­si­bil­i­ty of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA